Cargando…
Microcrystalline Tyrosine (MCT(®)): A Depot Adjuvant in Licensed Allergy Immunotherapy Offers New Opportunities in Malaria
Microcrystalline Tyrosine (MCT(®)) is a widely used proprietary depot excipient in specific immunotherapy for allergy. In the current study we assessed the potential of MCT to serve as an adjuvant in the development of a vaccine against malaria. To this end, we formulated the circumsporozoite protei...
Autores principales: | Cabral-Miranda, Gustavo, Heath, Matthew D., Gomes, Ariane C., Mohsen, Mona O., Montoya-Diaz, Eduardo, Salman, Ahmed M., Atcheson, Erwan, Skinner, Murray A., Kramer, Matthias F., Reyes-Sandoval, Arturo, Bachmann, Martin F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748599/ https://www.ncbi.nlm.nih.gov/pubmed/28953265 http://dx.doi.org/10.3390/vaccines5040032 |
Ejemplares similares
-
Shaping Modern Vaccines: Adjuvant Systems Using MicroCrystalline Tyrosine (MCT(®))
por: Heath, Matthew D., et al.
Publicado: (2020) -
Virus-Like Particle (VLP) Plus Microcrystalline Tyrosine (MCT) Adjuvants Enhance Vaccine Efficacy Improving T and B Cell Immunogenicity and Protection against Plasmodium
berghei/vivax
por: Cabral-Miranda, Gustavo, et al.
Publicado: (2017) -
MicroCrystalline Tyrosine-adsorbed immunotherapy
por: Al Saleh, Helal, et al.
Publicado: (2022) -
A meta‐analysis on allergen‐specific immunotherapy using MCT(®) (MicroCrystalline Tyrosine)‐adsorbed allergoids in pollen allergic patients suffering from allergic rhinoconjunctivitis
por: Becker, Sven, et al.
Publicado: (2021) -
Discovery of four new B-cell protective epitopes for malaria using Q beta virus-like particle as platform
por: Atcheson, Erwan, et al.
Publicado: (2020)